Eledon Pharmaceuticals, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Eledon Pharmaceuticals, Inc. (ELDN) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $23.26 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-04-02
- Eledon Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Eledon Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $0.00.
- Eledon Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $18.93M, a 270371.43% increase year-over-year.
- Eledon Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $4.33M.
- Eledon Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $23.26M, a 2325700.00% increase from fiscal 2016.
- Eledon Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $1.00K.
- Eledon Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$40.51M.
- Eledon Pharmaceuticals, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$175.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $18.93M derived: sum of 3 quarters · filed 2018-04-02 | $23.26M 10-K · filed 2018-04-02 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $18.93M derived: sum of 2 quarters · filed 2017-11-08 | $23.26M 10-Q · filed 2017-11-08 | $23.27M derived: sum of 4 quarters · filed 2018-04-02 | |||
| 2017-06-30 | $18.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $23.26M 10-Q · filed 2017-08-09 | $23.27M derived: sum of 3 quarters · filed 2018-04-02 | $23.27M derived: sum of 4 quarters · filed 2018-04-02 | |||
| 2017-03-31 | $4.33M 10-Q · filed 2017-05-03 | $4.34M derived: sum of 2 quarters · filed 2018-04-02 | $4.34M derived: sum of 3 quarters · filed 2018-04-02 | $4.34M derived: sum of 4 quarters · filed 2018-04-02 | |||
| 2016-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $11.00K derived: sum of 2 quarters · filed 2018-04-02 | $18.00K derived: sum of 3 quarters · filed 2018-04-02 | $1.00K 10-K · filed 2018-04-02 | $35.68M 10-K · filed 2017-03-03 | ||
| 2016-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $5.00K derived: sum of 2 quarters · filed 2017-11-08 | -$12.00K 10-Q · filed 2017-11-08 | $23.78M 10-Q · filed 2016-11-03 | -$328.00K derived: sum of 4 quarters · filed 2017-11-08 | ||
| 2016-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$10.00K 10-Q · filed 2017-08-09 | $8.13M 10-Q · filed 2016-08-04 | -$326.00K derived: sum of 3 quarters · filed 2017-08-09 | -$16.18M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2016-03-31 | -$17.00K 10-Q · filed 2017-05-03 | -$333.00K derived: sum of 2 quarters · filed 2017-05-03 | -$16.19M derived: sum of 3 quarters · filed 2017-05-03 | -$40.48M derived: sum of 4 quarters · filed 2017-05-03 | |||
| 2015-12-31 | -$316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$16.17M derived: sum of 2 quarters · filed 2017-03-03 | -$40.47M derived: sum of 3 quarters · filed 2017-03-03 | -$40.51M 10-K · filed 2017-03-03 | |||
| 2015-09-30 | -$15.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$40.15M derived: sum of 2 quarters · filed 2016-11-03 | -$40.19M 10-Q · filed 2016-11-03 | -$40.19M derived: sum of 4 quarters · filed 2017-03-03 | |||
| 2015-06-30 | -$24.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$24.34M 10-Q · filed 2016-08-04 | -$24.34M derived: sum of 3 quarters · filed 2017-03-03 | -$24.50M derived: sum of 4 quarters · filed 2017-03-03 | |||
| 2015-03-31 | -$45.00K 10-Q · filed 2016-05-10 | -$45.00K derived: sum of 2 quarters · filed 2017-03-03 | -$202.00K derived: sum of 3 quarters · filed 2017-03-03 | -$208.00K derived: sum of 4 quarters · filed 2017-03-03 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$157.00K derived: sum of 2 quarters · filed 2017-03-03 | -$163.00K derived: sum of 3 quarters · filed 2017-03-03 | -$175.00K 10-K · filed 2017-03-03 | |||
| 2014-09-30 | -$157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$163.00K derived: sum of 2 quarters · filed 2015-11-10 | -$175.00K 10-Q · filed 2015-11-10 | -$179.00K derived: sum of 4 quarters · filed 2016-03-10 | |||
| 2014-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$18.00K 10-Q · filed 2015-08-12 | -$22.00K derived: sum of 3 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | -$12.00K 10-Q · filed 2015-05-12 | -$16.00K derived: sum of 2 quarters · filed 2016-03-10 | |||||
| 2013-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | -$53.00K 10-K · filed 2016-03-10 | |||||
| 2013-09-30 | -$49.00K 10-Q · filed 2014-11-13 | ||||||
| 2012-12-31 | -$8.00K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |